Literature DB >> 27041639

[Female sexual dysfunction: Drug treatment options].

A Alcántara Montero1, C I Sánchez Carnerero2.   

Abstract

Many women will likely experience a sexual problem in their lifetime. Female sexual dysfunction is a broad term used to describe 3 categories of disorders of a multifactorial nature. Effective, but limited pharmacotherapeutic options exist to address female sexual dysfunction. The FDA recently approved the first agent for treatment of hypoactive sexual desire disorder in pre-menopausal women. Off-label use of hormonal therapies, particularly oestrogen and testosterone, are the most widely employed for female sexual dysfunction, particularly in post-menopausal women. Other drugs currently under investigation include phosphodiesterase inhibitors and agents that modulate dopamine or melanocortin receptors.
Copyright © 2016 Sociedad Española de Médicos de Atención Primaria (SEMERGEN). Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Disfunción sexual en mujeres; Flibanserin; Flibanserina; Hypoactive sexual desire disorder; Sexual dysfunction in women; Trastorno del deseo sexual hipoactivo

Mesh:

Substances:

Year:  2016        PMID: 27041639     DOI: 10.1016/j.semerg.2016.02.008

Source DB:  PubMed          Journal:  Semergen        ISSN: 1138-3593


  3 in total

1.  Biofeedback versus electrical stimulation for sexual dysfunction: a randomized clinical trial.

Authors:  Behnaz Aalaie; Behroz Tavana; Zahra Rezasoltani; Solmaz Aalaei; Jamshid Ghaderi; Afsaneh Dadarkhah
Journal:  Int Urogynecol J       Date:  2020-06-11       Impact factor: 2.894

2.  Hormonal effect on the relationship between migraine and female sexual dysfunction.

Authors:  Vasfiye Burcu Dogan; Hediye Dagdeviren; Ahmet Dirican; Ayten Ceyhan Dirican; Nurhan Kaya Tutar; Vidan Ayse Yayla; Hüseyin Cengiz
Journal:  Neurol Sci       Date:  2017-06-28       Impact factor: 3.307

3.  Evaluation of Sexual Function in Women with Hypogonadotropic Hypogonadism Using the Female Sexual Function Index (FSFI) and the Beck Depression Inventory (BDI).

Authors:  Mert Ulaş Barut; Hakan Çoksüer; Sibel Sak; Murat Bozkurt; Elif Ağaçayak; Uğur Hamurcu; Didem Kurban; Süleyman Eserdağ
Journal:  Med Sci Monit       Date:  2018-08-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.